Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2002

Conditions

Healthy

Interventions

DRUG

BIBR 953 ZW Intravenously

5 mg, 2.8 MBq (76 µCi)

DRUG

BIBR 1048 Oral Solution

200 mg free base, 2.8 MBq (76 µCi)